Related Experiment Videos
Motor cortex stimulation for deafferentation pain.
1Department of Neurosurgery, Osaka University Medical School, Osaka, Japan. saitoh@silver.ocn.ne.jp
Neurosurgical Focus
|March 8, 2006
Summary
Motor cortex stimulation (MCS) effectively reduced deafferentation pain in 10 of 15 patients. Ketamine sensitivity may predict successful outcomes for this chronic pain treatment.
Area of Science:
- Neurosurgery
- Pain Management
- Neurology
Background:
- Deafferentation pain presents a significant challenge in pain management.
- Motor cortex stimulation (MCS) is an emerging neuromodulation technique for intractable pain.
Purpose of the Study:
- To evaluate a modified motor cortex stimulation (MCS) protocol for treating deafferentation pain.
- To identify predictors of successful MCS treatment.
Main Methods:
- Fifteen patients with various deafferentation pain conditions underwent a modified MCS protocol.
- Preoperative pharmacological tests, including ketamine, were administered.
- Subdural electrode placement was used to optimize stimulation parameters and identify optimal positions for permanent devices.
Main Results:
- Ten out of fifteen patients (67%) experienced pain reduction, with four achieving excellent results.
- Pharmacological testing suggested that patients responsive to ketamine may be better candidates for MCS.
- Subdural electrode testing aided in determining the optimal placement for pain relief.
Conclusions:
- Test stimulation with subdural electrodes is effective in identifying optimal stimulation points for pain relief.
- Ketamine sensitivity appears to be a potential biomarker for predicting successful MCS outcomes in deafferentation pain patients.